Skip to main content
. 2018 Oct;24(10):1850–1858. doi: 10.3201/eid2410.172079

Table 4. Crude and adjusted odds ratios for maternal Zika virus infection and other risk factors and early childhood development, French Polynesia, 2013–2016*.

Risk factors
Early childhood development
Adequate in all domains, no. (%)
Question or problem in >1 domain, no. (%)
Adequate in all domains versus question or problem in >1 domain
Crude OR 
(95% CI)
Adjusted OR 
(95% CI)
LRT 
p value
Zika virus seropositivity, n = 107
No 13 (50) 13 (50) 1 1 0.07
Yes
46 (57)
35 (43)
0.76 (0.31–1.84)
0.35 (0.11–1.13)†

Reported Zika infection, n = 107
No infection during pregnancy‡ 19 (56) 15 (44) 1 1 0.19
Asymptomatic, timing unknown§ 30 (54) 26 (46) 1.09 (0.47–2.59) 0.51 (0.16–1.58)†
Symptomatic during pregnancy¶
10 (59)
7 (41)
0.89 (0.27–2.88)
0.58 (0.14–2.51)†

Deltamethrin outdoor spraying during pregnancy, n = 104
No 34 (69) 15 (31) 1 1 0.07
Yes
24 (44)
31 (56)
2.92 (1.30–6.57)
2.69 (0.92–7.84)#

Maternal socioeconomic status,** n = 106
Middle and high 47 (66) 24 (34) 1 1 <0.001
Low
11 (31)
24 (69)
4.27 (1.80–10.2)
5.28 (1.96–14.2)††

Breast-feeding,** n = 106
Yes, including artificial feeding 52 (57) 39 (43) 1 1 0.03
No 6 (40) 9 (60) 2.00 (0.66–6.09) 4.00 (1.06–15.1)‡‡

*LRT, likelihood ratio test; OR, odds ratio.
†Adjusted for deltamethrin outdoor spraying during pregnancy, maternal socioeconomic status, breastfeeding, and date of pregnancy start (divided into 4 categories based on risk of exposure to Zika virus; see Table 2).
‡Seronegative mothers and seropositive mothers who reported Zika-like illness outside pregnancy.
§Seropositive mothers who did not report Zika-like illness during or outside pregnancy.
¶Seropositive mothers who reported Zika-like illness during pregnancy.
#Adjusted for ZIKV seropositivity (main exposure), maternal socioeconomic status, breastfeeding, and date of pregnancy start.
**No interaction (test for interaction p = 0.26) and no multicolinearity were detected for maternal socioeconomic status and breastfeeding.
††Adjusted for ZIKV seropositivity (main exposure), deltamethrin outdoor spraying during pregnancy, breastfeeding, and date of pregnancy start.
‡‡Adjusted for ZIKV seropositivity (main exposure), deltamethrin outdoor spraying during pregnancy, maternal socioeconomic status, and date of pregnancy start.